377 Menopause and Its Relationship With Immunostaining and Tumor Growth Patterns in Nonfunctioning Pituitary Adenomas: A Clinicopathologic Study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
INTRODUCTION: As the pituitary gland plays an integral role in age-related hormonal changes, menopause status may influence nonfunctioning pituitary adenoma (NFPA) characteristics. The effects of menopause on pituitary adenoma characteristics have not been studied in detail. METHODS: We conducted a retrospective review of a prospectively maintained REDCap database from the University of Southern California Pituitary Center. Patients were included in the study if they were female patients diagnosed with an NFPA requiring surgical resection between 2012 and 2023. Patients were assigned to groups based on their menopausal status and presence of hypogonadotropic hypogonadism (HGHG). Univariable statistics were used to measure associations between menopausal status and HGHG status and immunohistochemistry and tumor invasion patterns. RESULTS: 96 (44.2%) pre-menopausal patients (average age 40.6 ± 7.1) and 121 (55.8%) post-menopausal patients (average age 59.7 ± 9.2) were included in the analysis. 185 (85.3%) patients had available IHC staining. NFPAs in post-menopausal women were more likely to stain for SF-1 (OR = 6.04, 95% CI: 1.90-19.19, p-value = 0.0030), and were less likely to stain for TPIT (OR= 0.22, 95% CI: 0.08-0.67, p-value = 0.0105) or TSH (OR = 0.08, 95% CI: 0.01-0.69, p-value = .0115). NFPAs in post-menopausal women were also more likely to exhibit infrasellar invasion (OR = 6.32, 95% CI: 1.73-23.09, p-value = 0.0051), except for post-menopausal women diagnosed with HGHG (OR = 0.30, 95% CI: 0.12-0.75, p-value = .0149). Pre-menopausal women on oral contraceptive pills (OCP) had tumors that were more likely to stain positive for ACTH (OR = 4.50, 95% CI: 1.42-14.25, p-value = 0.0179). Estrogen use in post-menopausal women was not associated with IHC subtype. Maximum tumor diameter was significantly larger in the pre-menopausal HGHG cohort (p-value = 0.05). CONCLUSIONS: Menopausal status is associated with differences in immunostaining subtype and NFPA growth patterns, with postmenopausal women being more likely to harbor tumors positive for SF-1 with infrasellar invasion, and less likely TPIT and TSH. The role of hormonal changes related to menopause and NFPA pathogenesis warrants further study.
Fields of Study & Subjects
Pituitary Gland Disorders and Treatments
Neuroendocrine Tumor Research Advances
Meningioma and schwannoma management
Publication details
- Journal / source
- Neurosurgery
- Volume
- 72
- Issue
- Supplement_1
- Pages
- 103–103
- Publication date
- 26 March 2026
- Language
- EN